Filter
324
Filtered Results: 324
Text search:
mRNA
Featured
Recommendations
62
New Publications
9
Language
Document type
Guidelines
103
Fact sheets
65
Studies & Reports
42
No document type
37
Videos
29
Manuals
13
Resource Platforms
11
Strategic & Response Plan
9
Training Material
5
Infographics
5
Situation Updates
3
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
17
Russia
12
Global
11
Ukraine
9
Latin America and the Carribbean
9
Middle East and North Africa
7
India
7
South Africa
5
Ecuador
5
Syria
4
Nigeria
4
Argentina
4
Yemen
4
Senegal
3
Mozambique
3
Africa
3
Lebanon
3
Eastern Europe
3
China
2
Kazakhstan
2
Chile
2
Niger
2
Peru
2
Haiti
2
Western and Central Europe
2
Belarus
2
Uganda
2
Sudan
2
Mali
2
South Sudan
2
Somalia
2
Colombia
1
Kenya
1
Mexico
1
El Salvador
1
Benin
1
Sierra Leone
1
Rwanda
1
Cameroon
1
Congo-Brazzaville
1
Burkina Faso
1
Morocco
1
Qatar
1
Mauritania
1
Dominican Republic
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Nicaragua
1
Egypt
1
Ethiopia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Iraq
1
Liberia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
COVID-19
85
Guidelines
35
Information, Education and Communication (IEC)
16
Policies
6
x MEDBOX Issue Brief & Annual Reports x
5
Cervical Cancer
5
Vaccine-preventable Diseases
5
Studies & Reports
5
Policies & Guidelines HIV & TB
4
Communicable Diseases
3
Capacity Building
3
TB
3
Cancer
2
Infection Control & Prevention (IPC)
2
Pediatrics
2
Humanitarian Crisis
2
Immunization
2
Health Systems
2
HIV & STI
2
Disease Prevention & Control
2
Hepatitis
1
Pharmacy & Technology
1
Disaster Preparedness
1
General Guidelines
1
MPOX - Monkeypox
1
Virology
1
Countries
1
Medical Devices & Equipment
1
Yellow Fever
1
Women & Child Health
1
Statistics
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
Non-communicable Diseases
1
Malaria
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19 Vaccination Information
35
Country specific documents
33
Videos
32
Communication Material
30
Vaccine Hesitancy & Myths
26
Immunization Guidelines
24
COVID-19 Vaccination
23
Biontech/Pfizer Comirnaty
21
Access & Strategy
15
For Migrants & Refugees
13
Infection Control General
12
For General Public & Community
12
mRna Vaccines general
11
Moderna
11
Logistics & Supply
10
Inactivated COVID-19 Vaccines
10
Clinical Guidelines
9
SARS-CoV-2 Variants
9
Vector-based Vacines General
9
Booster Doses
9
Fair Allocation & Ethical Aspects
8
Vaxzevria (Astra Zeneca)
7
Surveillance & Contact tracing
6
COVID-19 Information
6
Dashboards & Resource Platforms
6
Research & Pipeline
6
Vaccination
5
For Health Worker
5
Vaccine Candidates & Research
5
Anamnesis / Screening
4
Training, others
4
For Older People
4
Scientific & Research Studies
4
Blood Supply
4
Guidelines & Manuals
4
Prevention & Preparedness
3
Poster & Infographics
3
For Pregnant Women
3
Global Impact: Socio-economic, health services, TB & HIV
3
Educational Settings
3
Workplace
3
Physical Distancing
3
Mythbusters/Misinformation
3
COVAX Initiative
3
Information Refugees Ukraine
3
COVID-19
3
Male Circumcision
2
General Reports
2
Vaccines & Immunization
2
PPE Personel Protective Equipment
2
Treatment Guidelines
2
Diagnostics & Laboratory Guidance
2
For Parents & Children
2
Information for the Public
2
HIV and COVID-19
2
Tips & Best Practice Examples
2
Vaccination & Strategy
2
Long COVID/ Post-COVID Syndrome
2
Johnson & Johnson
2
Covaxin
2
Pharmacovigilance
2
Situation Reports & Updates
2
General
2
Education material
2
Health Financing Toolbox
2
Drug resistant TB
2
Research & Access
2
Neurological disorders, Others
2
Gynaecology / Obstetrics
1
Laboratory Guidance
1
Agriculture & Veterinary
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Treatment & Prevention
1
Clinical Aspects
1
Influenza Prevention & Control
1
Diagnosis & Treatment PTSD in Children
1
Pediatrics
1
Information for Refugees & Migrants
1
Neuropsychology of Trauma
1
Hepatitis
1
Public Health
1
HIV
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Clinical aspects
1
Mental Health Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Context & Facts, Travel Advice
1
Online Courses & Resources
1
COVID-19
1
Public Health
1
PPE Personel Protective Equipment
1
Video & Audio
1
For People with Disabilities
1
Appeals and Response Plans
1
Dashboards & Maps
1
Resource Platforms others
1
Gender Aspects
1
Paediatrics
1
COVID-19
1
Hospital Readiness/Essential Health Services
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
TB/HIV
1
Genomic sequencing
1
TB/COVID-19
1
Sputnik V
1
Chile
1
Essential Medicines
1
Prices and Patents
1
Pharmacy Practice
1
Supply Chain & Store Management
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
General Guidelines for Rational Use
1
Ukraine
1
Zoonoses
1
MPOX - Monkeypox
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Dracunculiasis (guinea-worm disease)
1
General Information
1
Prevention & Strategies
1
Studies & Reports
1
Studies & Reports
1
Women
1
Global Overview
1
Detection & Diagnosis
1
Co-Morbidities (except TB)
1
Human Rights & the Right to Health
1
Nutrition
1
Technical Information
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Antiretroviral Treatment ART
1
TB
1
War, Conflict Areas & Refugees
1
Depression
1
Studies & Reports
1
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Existen notificaciones de eventos relacionados con la vacuna (ESAVI) de
miocarditis/pericarditis en adolescentes tras la administración de vacunas ARNm(Pfizer y Moderna) especialmente tras la segunda dosis. Al momento no seencuentra asociación entre la enfermedad y la administración de la vacuna...
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Vaccine handling, storage and Transportation of Pfizer BioNTech
COVID-19 COMIRNATY® (Tozinameran)
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
– векторною вакциною – (Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson)
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit Vektor-Impfstoff – (COVID-19 Vacc...
(Первинна та бустерна вакцинації) – з векторною вакциною – (вакцина Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson
Станом на: 14 лютого 2022 р. (даний інформаційн...
ІНФОРМАЦІЙНИЙ ЛИСТ Для вакцинації проти COVID-19 (коронавірусне захворювання 2019 р.) (Первинна вакцинація)
recommended
– з вакциною на білковій основі
(Nuvaxovid® виробництва Novavax)
Станом на: 15 лютого 2022 р. (даний інформаційний лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Cor...
Wenn geflüchtete Menschen aus Kriegs- oder Krisengebieten, wie der Ukraine, nach Deutschland kommen, sollten ihnen frühzeitig alle Impfungen angeboten werden, die die Ständige Impfkommission (STIKO) für die in Deutschland lebende Bevölkerung empfiehlt. Ein aktueller Impfschutz ist entscheidend,...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br...
22 February 2022
In dieser Fokuserhebung wurde die deutschsprachige Erhebung durch Interviews in weiteren fünf Sprachen ergänzt. Damit wurden in dieser Erhebung auch Personengruppen erreicht, die in vorherigen Erhebungen aufgrund einer Sprachbarriere nicht erreicht werden konnten. Insgesamt liefert diese Befragung...
Dracunculiasis (Guinea worm disease), caused by the parasite Dracunculus medinensis, is traditionally acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae, but in recent years also appears increasingly to be transmitted by eating fish or other aquatic anima...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
